Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Dec 27;13(1):23022.
doi: 10.1038/s41598-023-50006-6.

Multimedia-based hormone therapy information program for patients with prostate cancer: the result of a randomized pilot study

Ching-Hui Chien  1 , Kuan-Lin Liu  2 , Cheng-Keng Chuang  3   4 , Chun-Te Wu  3   4 , Ying-Hsu Chang  4   5 , Kai-Jie Yu  3   4
Affiliations
Randomized Controlled Trial

Multimedia-based hormone therapy information program for patients with prostate cancer: the result of a randomized pilot study

Ching-Hui Chien et al. Sci Rep. .

Abstract

Few studies have explored the feasibility and efficacy of a multimedia information intervention for patients with prostate cancer who are undergoing hormone therapy. Thus, the purpose of the study was to assess the feasibility, acceptability, and the preliminary results of a multimedia-based hormone therapy information program (HTIP) on positive thinking and quality of life (QOL; primary outcomes) as well as social support and self-efficacy (secondary outcomes) of patients with prostate cancer. Patients with prostate cancer who were receiving hormone therapy were recruited from hospitals. After completing the pre-test questionnaire, patients were randomly divided into the multimedia information group (MIG; n = 40) and the control group (CG; n = 40). Patients in the MIG received a multimedia-based HTIP once a week for 6 weeks. Data were collected at 8 and 12 weeks after the pre-test. Measurement variables included positive thinking, QOL, social support, self-efficacy, and satisfaction with the program. The recruitment rate and retention rate were calculated for assessment of feasibility. The study had a 96.3% retention rate, and patients in the MIG were satisfied with the program. Preliminary results showed that, compared with those in the CG, patients in the MIG tended to exhibit higher positive thinking, prostate cancer-specific QOL, and social support at 8 weeks and 12 weeks after pre-test; however, the effect did not reach a statistically significant level. A multimedia-based HTIP is considered feasible and acceptable in patients with prostate cancer who underwent hormone therapy. Further research with a larger sample size, patients with high homogeneity in early-stage disease and long-term follow-up is needed to assess the efficacy of the intervention program.Trial registration: ClinicalTrials.gov (NCT04693910); Registered 05/01/2021.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Conceptual framework of the multimedia-based information program.
Figure 2
Figure 2
Flowchart of participant recruitment and follow-up.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Eggener S. Hormonal therapy for prostate cancer. In: Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, editors. Campbell-Walsh-Wein Urology. 12. Elsevier; 2021. pp. 3671–3686.
    1. Pienta KJ, Bradley D. Mechanisms underlying the development of androgen-independent prostate cancer. Clin. Cancer Res. 2006;12(6):1665–1671. doi: 10.1158/1078-0432.Ccr-06-0067. - DOI - PubMed
    1. Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, et al. Quality of life in men living with advanced and localised prostate cancer in the UK: A population-based study. Lancet Oncol. 2019;20(3):436–447. doi: 10.1016/s1470-2045(18)30780-0. - DOI - PubMed
    1. Chien CH, Huang XY. Self-care experiences of advanced prostate cancer survivors who underwent androgen deprivation therapy. Cancer Nurs. 2022;45(3):190–200. doi: 10.1097/ncc.0000000000000933. - DOI - PubMed

Publication types

Associated data